Steatotic liver disease induces YAP/TAZ-driven cell competition that can suppress tumor initiation
{{output}}
Background & aims: Metabolic dysfunction-associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction-associated steatohepatitis (MASH), are leading risk factors for liver cancer. While inflammation ... ...
